tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Mangoceuticals Settles Lawsuit with Stock Issuance

Story Highlights
  • Mangoceuticals borrowed $100,000 with an 18% interest rate, maturing by May 2, 2026.
  • The company settled a lawsuit by issuing 62,500 shares, raising its total shares to 11,034,023.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Mangoceuticals Settles Lawsuit with Stock Issuance

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

The latest update is out from Mangoceuticals, Inc. ( (MGRX) ).

On May 2, 2025, Mangoceuticals, Inc. borrowed $100,000 from The Tiger Cub Trust, controlled by CEO Jacob D. Cohen, through a Promissory Note with an 18% annual interest rate, maturing by May 2, 2026, or upon a Qualified Financing event. The note includes terms for prepayment and default, with a mandatory prepayment clause triggered by a Qualified Financing. Additionally, on May 5, 2025, Mangoceuticals settled a lawsuit with 1800 Diagonal Lending, LLC by issuing 62,500 shares of restricted common stock, increasing its outstanding shares to 11,034,023.

More about Mangoceuticals, Inc.

Average Trading Volume: 284,004

Technical Sentiment Signal: Sell

Current Market Cap: $10.5M

See more data about MGRX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1